6533b82cfe1ef96bd128feee
RESEARCH PRODUCT
Prevalence of SARS-CoV-2-IgG Antibodies in Children with CKD or Immunosuppression
Morello WilliamMastrangelo AntonioGuzzo IsabellaCusinato LisaAnnicchiarico Petruzzelli LuigiBenevenuta ChiaraMartelli LauraDall'amico RobertoVianello Federica AlessandraPuccio GiuseppeMassella LauraBenetti ElisaPecoraro CarminePeruzzi LiciaMontini GiovanniVidal Enricosubject
2019-20 coronavirus outbreakAdolescentCoronavirus disease 2019 (COVID-19)Epidemiologymedicine.medical_treatmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antibodies ViralCritical Care and Intensive Care MedicineIdiopathic Nephrotic SyndromeImmunoglobulin GPandemicPrevalenceResearch LetterHumansMedicineRenal Insufficiency ChronicChildImmunosuppression TherapyTransplantationbiologySARS-CoV-2business.industryCOVID-19InfantImmunosuppressionNephrologyChild PreschoolImmunoglobulin GImmunologybiology.proteinAntibodybusinessdescription
Coronavirus disease 2019 (COVID-19) rapidly spread from China as a pandemic, with Italy one of the most affected countries worldwide. Unlike adults, children have a milder presentation of COVID-19, even when affected by CKD or on immunosuppressive therapy for glomerulopathies and kidney
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2021-07-01 | Clinical Journal of the American Society of Nephrology |